ZA904565B - Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection - Google Patents

Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection

Info

Publication number
ZA904565B
ZA904565B ZA904565A ZA904565A ZA904565B ZA 904565 B ZA904565 B ZA 904565B ZA 904565 A ZA904565 A ZA 904565A ZA 904565 A ZA904565 A ZA 904565A ZA 904565 B ZA904565 B ZA 904565B
Authority
ZA
South Africa
Prior art keywords
peptides
infection
diagnosis
therapy
derived therefrom
Prior art date
Application number
ZA904565A
Other languages
English (en)
Inventor
Anders Vahlne
Vahlne Anders
Bo Svennerholm
Svennerholm Bo
Peter Horal
Horal Peter
Stig Jeansson
Jeansson Stig
Lars Rymo
Rymo Lars
Original Assignee
Virovahl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virovahl Sa filed Critical Virovahl Sa
Publication of ZA904565B publication Critical patent/ZA904565B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA904565A 1989-06-13 1990-06-13 Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection ZA904565B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902148A SE467542B (sv) 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar

Publications (1)

Publication Number Publication Date
ZA904565B true ZA904565B (en) 1991-03-27

Family

ID=20376281

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904565A ZA904565B (en) 1989-06-13 1990-06-13 Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection

Country Status (11)

Country Link
EP (2) EP0814090A1 (sv)
JP (1) JP2650217B2 (sv)
KR (1) KR0151860B1 (sv)
AU (2) AU638727B2 (sv)
CA (1) CA2062713A1 (sv)
FI (1) FI915702A0 (sv)
HU (1) HUT61323A (sv)
NZ (1) NZ234049A (sv)
SE (1) SE467542B (sv)
WO (1) WO1990015820A1 (sv)
ZA (1) ZA904565B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
JP2807287B2 (ja) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 ペプチドおよびその用途
FI910245A (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
WO1992004046A1 (en) * 1990-08-29 1992-03-19 The United States Of America, Represented By The Secretary, United States Department Of Commerce Novel peptide antigens and immunoassays, test kits and vaccines using the same
US5866137A (en) * 1990-10-12 1999-02-02 Benjamin Rovinski Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins
ATE180495T1 (de) * 1991-07-10 1999-06-15 Abbott Lab Unterscheidung von htlv-i und htlv-ii unter verwendung von synthetischen peptiden
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
JP3506252B2 (ja) * 1992-02-24 2004-03-15 ジェネラブス・テクノロジーズ・インコーポレイテッド Ｈｔｌｖ−ｉ／ｈｔｌｖ−ｉｉの分析及び方法
US6406841B1 (en) 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
EP0736179A1 (en) * 1993-12-20 1996-10-09 Abbott Laboratories Differentiation of htlv-i and htlv-ii using synthetic peptides
FR2844514B1 (fr) * 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
JP2015215244A (ja) * 2014-05-12 2015-12-03 富士レビオ株式会社 免疫測定における抗ｈｔｌｖ抗体の検出感度を向上させる方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572800A (en) * 1982-09-30 1986-02-25 Otsuka Pharmaceutical Co., Ltd. Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
US4525300A (en) * 1983-01-07 1985-06-25 Japanese Foundation For Cancer Research Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
JPS6028993A (ja) * 1983-07-22 1985-02-14 Otsuka Pharmaceut Co Ltd ヒト白血病ウイルス関連ペプチド
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
WO1989006543A1 (en) * 1988-01-12 1989-07-27 Genelabs Incorporated Htlv-i peptide antigen and assay
JPH02209889A (ja) * 1988-02-08 1990-08-21 Univ Duke 合成親水性ペプチド
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
JPH0628993A (ja) * 1992-07-10 1994-02-04 Fujitsu Ltd 電子ビーム装置

Also Published As

Publication number Publication date
SE8902148L (sv) 1990-12-14
EP0814090A1 (en) 1997-12-29
HUT61323A (en) 1992-12-28
NZ234049A (en) 1993-02-25
JPH04506077A (ja) 1992-10-22
HU906639D0 (en) 1992-02-28
KR0151860B1 (ko) 1998-10-01
AU638727B2 (en) 1993-07-08
AU654240B2 (en) 1994-10-27
SE8902148D0 (sv) 1989-06-13
AU4890693A (en) 1993-12-16
SE467542B (sv) 1992-08-03
CA2062713A1 (en) 1990-12-14
KR920702688A (ko) 1992-10-06
EP0477301A1 (en) 1992-04-01
AU5945390A (en) 1991-01-08
FI915702A0 (fi) 1991-12-03
JP2650217B2 (ja) 1997-09-03
WO1990015820A1 (en) 1990-12-27

Similar Documents

Publication Publication Date Title
GB2213823B (en) Synthetic peptides for use in the diagnosis and prevention of influenza virus infection
KR0125921B1 (en) Method and device for the diagnosis and treatment of nasal diseases
HUT64480A (en) An improved vaccine of meningococcus-polysaccharide conjugate
AU7553587A (en) Diagnostic peptides of human papilloma virus
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
AU5184190A (en) Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
IL90690A0 (en) Tissue equivalents and their preparation
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
EP0506893A4 (en) Diagnosis and treatment of diseases
IL89793A0 (en) Pharmaceutical composition for treating patients having a retrovirus infection and method for the preparation thereof
OA09658A (en) Materials and methods for the treatment of foreign tissue
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
EP0453497A4 (en) Treatment methods and vaccines
DK134990D0 (da) Praeparat til tandbehandling samt fremgangsmaade til fremstilling deraf
EP0467972A4 (en) Rickettsial antigens for vaccination and diagnosis
AU632545B2 (en) Hog cholera virus vaccine and diagnostic
HU900666D0 (en) Process for preparing the way for elimination of articulational mistake on human jaw-bone and palate
GB8728000D0 (en) Immunologically active polypeptides useful for preparation of antimalarial vaccines and of diagnostic kits
HU896052D0 (en) Process for the preparation of peptides with t-cell suppressoral activity and medical preparations containing such peptides
HU905823D0 (en) Medical preparations
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
AU2715288A (en) Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein
GB2193215B (en) Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
GB2248186B (en) Preparation of vaccines